866-326-3365 
Drug-induced psychosis, also known as substance-induced psychotic disorder, is a serious mental health condition in which hallucinations, delusions, or a complete break from reality are triggered directly by substance use or withdrawal. It occurs with a wide range of drugs — including cannabis, methamphetamine, cocaine, alcohol, and hallucinogens — and in some cases progresses to a lasting psychotic disorder if left untreated.
Key Highlights
- Cannabis carries the highest transition risk: Around 34% of people with cannabis-induced psychosis later develop schizophrenia, the highest rate of any substance (Radua et al., 2011).
- 1 in 4 cases can become permanent: Approximately 25% of those diagnosed with substance-induced psychosis go on to develop a schizophrenia spectrum disorder (Murray et al., 2021).
- Recovery timelines vary by drug: Around 60% of meth-induced psychosis cases resolve within one month of sobriety; however, 10% have symptoms lasting over six months (Chen et al., 2010).
- Dual diagnosis is very common: In one study, 62% of patients hospitalized for first-episode psychosis met the criteria for an active substance use disorder at the time of the episode (Greenhouse Treatment, 2024).
- Early treatment reduces the risk of permanent psychosis: Conversion to schizophrenia or bipolar disorder can affect up to 1 in 3 individuals, with cannabis users and those with early-onset substance abuse at highest risk (Baldaçara et al., 2024).
What Is Drug-Induced Psychosis?
Drug-induced psychosis is a psychiatric condition characterized by hallucinations (sensing things that are not there), delusions (fixed false beliefs), or disorganized thinking that develops during or within a month of substance intoxication or withdrawal. The DSM-5 (Diagnostic and Statistical Manual of Mental Disorders, 5th Edition) classifies it as a distinct diagnosis, separate from primary psychotic disorders like schizophrenia.
Psychosis is not a standalone illness. It is a group of symptoms that disrupts how a person thinks and perceives reality. The condition can occur with a single use in vulnerable individuals or develop gradually after prolonged heavy use.
Unlike schizophrenia or bipolar-related psychosis, drug-induced psychosis typically resolves after the substance leaves the body. However, it should never be dismissed as temporary — repeated episodes significantly increase the risk of a permanent psychiatric diagnosis.
What Substances Cause Drug-Induced Psychosis?
Cannabis, methamphetamine, and cocaine carry the highest risk of persistent psychosis following a drug-induced episode.
Substances that cause drug-induced psychosis are both legal and illicit compounds that disrupt neurochemical balance during intoxication or withdrawal. The risk depends on the type of drug, the dose, frequency of use, age of first use, and individual genetic vulnerability. The table below outlines the most commonly implicated substances.
| Substance | Psychosis Risk | Common Symptoms |
|---|---|---|
| Cannabis (THC) | High — 34% develop schizophrenia | Paranoia, depersonalization, altered time perception |
| Methamphetamine | High — 30% develop schizophrenia | Auditory/visual hallucinations, formication, persecutory delusions |
| Cocaine | High — up to 90% report paranoid delusions | Persecutory delusions, visual hallucinations, agitation |
| Alcohol (withdrawal) | Moderate — 10% schizophrenia transition | Auditory hallucinations, delirium tremens, confusion |
| Hallucinogens (LSD, psilocybin, PCP) | Moderate — 26% may develop schizophrenia | Visual distortions, depersonalization, HPPD |
| Amphetamines | Moderate — 22% may develop schizophrenia | Persecutory delusions, paranoia, tactile hallucinations |
| Synthetic cannabinoids (K2/Spice) | Emerging — higher acute risk than natural cannabis | Severe paranoia, agitation, excited delirium |
| Benzodiazepines (withdrawal) | Low — 9% schizophrenia transition | Anxiety, perceptual disturbances, delirium |
Synthetic substances deserve special attention. Synthetic cannabinoids (sold as K2 or Spice) are far more potent than natural cannabis and are increasingly linked to severe, acute psychotic episodes. Synthetic cathinones, also called bath salts, can produce an extreme agitated state sometimes described as excited delirium, with psychotic symptoms ranging from mild to severe (Castaldelli-Maia et al., 2021).
How Does Drug-Induced Psychosis Affect the Brain?
Substance-induced psychosis affects the brain by disrupting the same neurotransmitter (brain chemical messenger) systems that are affected in primary psychotic disorders. Most psychosis-producing drugs disturb dopamine signaling — the pathway involved in reward, motivation, and the interpretation of sensory information.
Stimulants like methamphetamine and cocaine flood the brain with dopamine, which can produce persecutory delusions and auditory or tactile hallucinations that closely mimic schizophrenia.
Cannabis acts through the endocannabinoid system and can disrupt dopamine regulation, particularly in adolescents whose brains are still developing. High-THC (tetrahydrocannabinol, the active compound in cannabis) products significantly amplify this risk.
Alcohol-induced psychosis typically results from prolonged heavy use or severe withdrawal. Delirium tremens (DTs), a life-threatening form of alcohol withdrawal, can produce vivid hallucinations and extreme disorientation.
Chronic alcohol use can also cause thiamine (vitamin B1) deficiency, bringing about Wernicke-Korsakoff syndrome, a neurological condition with lasting effects on memory and perception. For more on alcohol-related risks and treatment, professional support is critical.
Begin your journey to recovery with personalized drug & alcohol rehab—verify your insurance coverage in under a minute. Check your coverage online now.
What Are the Symptoms of Drug-Induced Psychosis?
Drug-induced psychosis symptoms are defined by three core features: hallucinations, delusions, and disorganized thinking. Additional symptoms vary depending on the substance involved.
Common Symptoms Across All Substances
- Hallucinations: Hearing voices, seeing things that are not there, or feeling sensations with no physical cause (auditory, visual, and tactile hallucinations are all possible)
- Delusions: Firmly held false beliefs, often paranoid in nature — such as believing one is being followed, poisoned, or monitored
- Disorganized thinking: Difficulty staying on topic, incoherent speech, or the inability to follow a logical sequence of thought
- Agitation and hostility: Increased aggression or extreme emotional reactivity
- Cognitive impairment: Memory problems, poor concentration, and difficulty making decisions
How Symptoms Differ by Substance
Stimulants (cocaine, meth, amphetamines): Persecutory delusions are very common, along with formication — the feeling of insects crawling under the skin. Auditory and visual hallucinations occur with heavy or prolonged use.
Cannabis: Paranoia, an altered sense of time, depersonalization (feeling detached from yourself or your surroundings), and sensory distortion. Adolescent users are at significantly higher risk.
Hallucinogens (LSD, psilocybin, PCP): Vivid visual distortions, depersonalization, and, in rare cases, HPPD (hallucinogen persisting perception disorder), which causes lasting visual disturbances even after the drug has left the body.
Alcohol (withdrawal): Primarily auditory hallucinations (hearing voices that are not there), confusion, and, in severe cases, delirium tremens.
How Long Does Drug-Induced Psychosis Last?
The duration of drug-induced psychosis varies considerably depending on the substance used, the dose, how long the person has been using, and whether an underlying mental health condition exists.
| Substance | Typical Duration | Notes |
|---|---|---|
| Cannabis | Hours to a few days | Most cases resolve within a week with abstinence and sleep |
| Cocaine | Minutes to 24 hours | High-dose use can trigger psychosis almost immediately |
| Methamphetamine | Days to months | 60% resolve within 1 month; 10% last over 6 months |
| Hallucinogens (LSD, PCP) | Hours to days | HPPD may cause persistent visual disturbances in rare cases |
| Alcohol (withdrawal) | Days to 1 week | Delirium tremens peaks at 48–72 hours after last drink |
| General (all substances) | Most resolve within 30 days of sobriety | Symptoms beyond 30 days require full psychiatric evaluation |
As a general benchmark, drug-induced psychosis is expected to resolve within 30 days of sobriety (Baldaçara et al., 2024). When symptoms persist beyond this window, a full psychiatric evaluation is needed to rule out a primary psychotic disorder. Methamphetamine is a notable outlier: psychotic symptoms can spontaneously reappear in individuals who have been drug-free for extended periods due to lasting changes in dopamine circuitry.
Contact us today to schedule an initial assessment. We are here to help.
Can Drug-Induced Psychosis Turn Into Schizophrenia?
Transition rates from substance-induced psychosis to schizophrenia differ significantly by drug type. Source: Murray et al., 2021.
Yes, drug-induced psychosis can transition to a permanent schizophrenia spectrum disorder in a substantial number of cases. A large meta-analysis covering more than 34,000 individuals found that 25% of those with substance-induced psychosis later developed schizophrenia (Murray et al., 2021). Transition rates vary considerably by substance.
Cannabis carries the highest risk at 34%, followed by hallucinogens at 26% and amphetamines at 22% (Murray et al., 2021). Alcohol, opioid, and sedative-induced psychoses showed lower transition rates of 10%, 12%, and 9%, respectively. A 2023 Norwegian registry study of more than 3,000 patients reported a six-year cumulative transition rate of 27.6% to schizophrenia spectrum disorder (Rognli et al., 2023).
Risk factors that raise the likelihood of permanent psychosis comprise: younger age at first substance use, a family history of psychotic disorders, longer duration of untreated psychosis, repeated hospitalizations for drug-induced episodes, and male sex in the context of cannabis use. This link is why identifying and treating co-occurring mental health and substance use disorders together is so important.
Who Is at Risk for Drug-Induced Psychosis?
Not everyone who uses substances will experience psychosis. Several factors influence individual vulnerability, and understanding them aids in identifying who needs the most support.
- Genetic predisposition: A family history of schizophrenia, bipolar disorder, or other psychotic illnesses significantly raises the risk, particularly with cannabis and stimulant use.
- Age of first use: Adolescents who use cannabis or stimulants are at substantially higher risk because the brain is still developing. Using cannabis in teenage years nearly doubles the risk of later developing schizophrenia (Alcohol and Drug Foundation, 2024).
- Dose and potency: Higher doses and more potent substances, especially high-THC cannabis concentrates, amplify both the likelihood and severity of psychotic symptoms.
- Polysubstance use: Combining multiple substances amplifies the risk of severe, prolonged psychosis.
- Underlying mental health conditions: People with existing anxiety, depression, bipolar disorder, or trauma histories are more vulnerable to substance-induced psychosis.
- Sleep deprivation: Sleep loss, which is common with stimulant use, is a major contributing factor to the onset and duration of psychotic symptoms.
How Is Drug-Induced Psychosis Treated?
Drug-induced psychosis is treated as follows by prioritizing immediate safety, rapid stabilization, and the clinical removal of the triggering substance from the system. For a substance like alcohol, this requires a medically supervised detox, as unsupervised withdrawal is life-threatening.
Are you covered for treatment?
Carolina Center for Recovery works with most major insurance providers to make high-quality care accessible and affordable.
Check Coverage Now!Immediate Treatment
The acute phase of psychosis may require hospitalization for close monitoring. Short-term antipsychotic medications can reduce hallucinations and delusions. Benzodiazepines may be used to manage agitation safely. The goal at this stage is stabilization, not long-term medication management.
Ongoing Treatment
Once the acute episode is resolved, treating the underlying substance use disorder is essential to preventing recurrence. Cognitive behavioral therapy (CBT) has strong evidence for both psychosis and addiction. Integrated dual diagnosis treatment, which addresses substance use and mental health simultaneously, has been shown to double the likelihood of remission in early psychosis (Murray et al., 2021). For those struggling with cocaine addiction, methamphetamine, or other stimulants, individualized residential treatment offers the most structured path to recovery.
Relapse prevention is central to long-term recovery. Both medication-based strategies (such as naltrexone for alcohol use disorder) and behavioral approaches, such as ongoing therapy, peer support groups, and structured outpatient rehab programs, lower the risk of repeated psychotic episodes.
Frequently Asked Questions
Rediscover Life at Carolina Center for Recovery
At Carolina Center for Recovery, we’re here to help you or your loved one take the first step toward lasting recovery and a brighter future.
Our Team
Can a single use of a drug cause psychosis?
Yes, a single use of a drug can cause psychosis. In some individuals, a single use of a high-potency substance, such as synthetic cannabinoids, PCP, or high-dose LSD, triggers a psychotic episode. The risk depends heavily on genetics, prior mental health history, and the potency of the substance.
Is drug-induced psychosis the same as a bad trip?
Not exactly. A bad trip involves intense fear, anxiety, or disturbing hallucinations during the acute effects of a drug. Drug-induced psychosis is a clinical condition in which psychotic symptoms — particularly delusions — persist beyond the period of intoxication and may not resolve without medical treatment.
How can you tell drug-induced psychosis apart from schizophrenia?
You can tell drug-induced psychosis apart from schizophrenia primarily by the timing of the symptoms and their relationship to substance use. Distinguishing the two is difficult. The key clinical indicator is timing: if symptoms appeared only during or shortly after substance use and resolve with sustained abstinence, drug-induced psychosis is the most likely diagnosis. If symptoms persist beyond one month of sobriety, a primary psychotic disorder must be considered. A thorough psychiatric evaluation and substance use history are essential for accurate diagnosis.
Begin your journey to recovery with personalized drug & alcohol rehab—verify your insurance coverage in under a minute. Check your coverage online now.
Can drug-induced psychosis be permanent?
No, in most cases, drug-induced psychosis resolves with abstinence. Conversely, a minority of people — roughly 1 in 4 — go on to develop a permanent schizophrenia spectrum disorder. The risk is highest with cannabis, hallucinogens, and amphetamines, and increases with earlier age of first use and repeated psychotic episodes.
What should you do if someone is experiencing drug-induced psychosis?
You should prioritize safety first if someone is experiencing drug-induced psychosis. Stay calm and avoid confrontation. Remove any dangerous objects from the environment. Do not leave the person alone. If the person is at risk of harming themselves or others, call 911 immediately. Even if symptoms appear mild, medical evaluation is strongly recommended, as it is not possible to predict how the episode will progress without professional assessment.
Summary
Drug-induced psychosis is a serious but treatable condition that can arise from a wide range of substances, with cannabis, methamphetamine, and cocaine carrying the highest risk of long-term psychiatric consequences.
If you or someone you care about is experiencing symptoms of psychosis related to substance use, professional treatment makes all the difference. South Carolina Addiction Treatment provides medically supervised detox and integrated dual diagnosis care for people dealing with substance use and co-occurring mental health conditions — in addition to those recovering from a substance-induced psychotic episode.
References
Alcohol and Drug Foundation. (2024). What is drug-induced psychosis? https://adf.org.au/insights/drug-induced-psychosis/
Baldaçara, L., Ramos, A., & Castaldelli-Maia, J. M. (2024). Managing drug-induced psychosis. International Review of Psychiatry, 35(5–6), 496–502. https://doi.org/10.1080/09540261.2023.2261544
Castaldelli-Maia, J. M., Bhugra, D., & de Quevedo, J. L. (2021). Substance-induced psychoses: An updated literature review. Frontiers in Psychiatry, 12, 694863. https://pmc.ncbi.nlm.nih.gov/articles/PMC8732862/
Chen, C. K., Lin, S. K., Sham, P. C., Ball, D., Loh, E. W., & Murray, R. M. (2010). Long-term follow-up of patients treated for psychotic symptoms that persist after stopping illicit drug use. Psychological Medicine, 40(9), 1513–1520. https://pmc.ncbi.nlm.nih.gov/articles/PMC4198875/
Grassi, L., & Palagini, L. (2024). Substance-induced psychosis: Diagnostic challenges and phenomenological insights. Brain Sciences, 14(10), 52. https://doi.org/10.3390/brainsci14010052
Murray, R. M., Bhavsar, V., Tripoli, G., & Howes, O. (2021). 30 years on: How the neurodevelopmental hypothesis of schizophrenia morphed into the developmental risk factor model, opening the way for primary prevention. Schizophrenia Bulletin, 47(5), 1190–1196. Referenced via: Radua, J., et al. (2011). Transition of substance-induced, brief, and atypical psychoses to schizophrenia: A systematic review and meta-analysis. Schizophrenia Bulletin, 46(3), 505–516. https://doi.org/10.1093/schbul/sbz102
Rognli, E. B., Heiberg, I. H., Jacobsen, B. K., Bramness, J. G., & Høye, A. (2023). Transition from substance-induced psychosis to schizophrenia spectrum disorder or bipolar disorder. American Journal of Psychiatry, 180(6), 437–444. https://doi.org/10.1176/appi.ajp.22010076
National Institute of Mental Health. (2023). Understanding psychosis. https://www.nimh.nih.gov/health/publications/understanding-psychosis
Substance Abuse and Mental Health Services Administration. (2023). Co-occurring disorders and other health conditions. https://www.samhsa.gov/co-occurring-disorders
